Delivery Order SPE2DB25D7068-SPE2DB25FTXDU
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a firm fixed price of $1,770.52 and a completion date of May 21, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a ceiling value of $6,980.96 and a period of performance through May 2, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a firm fixed price ceiling value of $6,317.62. The contract has an ultimate completion date of June 5, 2025. This award is not set-aside and was competitively awarded. AmerisourceBergen holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $19,271.00 and is a firm fixed-price contract type. The ultimate completion date for this delivery order is July 8, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML pharmaceutical products. The contract has a total potential value of $8,961.84 and a completion date of February 15, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The contract has a potential value of $8,961.84 and a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- This is a $1,666.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a period of performance through April 14, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,576.64, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML medical supplies. The award is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,219.79 contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML pharmaceutical products to be completed by February 12, 2024. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the sole...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EUFLEXXA 20 MG/2 ML syringes. The $8,961.84 contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is likely part of a larger indefinite delivery contract (IDC) that the company holds with DLA Troop Support Medical to supply pharmaceuticals and medical...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTXDUDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $3,090.60 and is a firm fixed-price delivery order with a completion date of July 7, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/3/25 |